Cisplatin, Irinotecan, and Bevacizumab for Untreated Extensive-Stage Small-Cell Lung Cancer: CALGB 30306, a Phase II Study
- Citation:
- J Clin Oncol vol 29 (33) 4436-4441
- Year:
- 2011
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Book Volume:
- 1
- Parents:
- 628
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- CA33601, CA41287, U10 CA031946, U10 CA033601, U10 CA041287, CA31946
- Corr. Author:
- Authors:
- Neal E. Ready Arkadiusz Z. Dudek Herbert H. Pang Lydia D. Hodgson Stephen L. Graziano Mark R. Green Everett E. Vokes
- Networks:
- Study
- CALGB-30306
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Thor11, To1, Original Reports, Thoracic Oncology